| Literature DB >> 34041505 |
Shujing Sun1, Xiaoyan Zhang2,3, Kong Chen1,4, Xiaohong Zhu2,3, Yang Zhao1,2.
Abstract
Environmental stimuli evoke transient increases of the cytosolic Ca2+ level. To identify upstream components of Ca2+ signaling, we have optimized two forward genetic screening systems based on Ca2+ reporter aequorin. AEQsig6 and AEQub plants were used for generating ethyl methanesulfonate (EMS)-mutagenized libraries. The AEQsig6 EMS-mutagenized library was preferably used to screen the mutants with reduced Ca2+ signal response due to its high effectiveness, while the AEQub EMS-mutagenized library was used for screening of the mutants with altered Ca2+ signal response. For complete details on the use and execution of this protocol, please refer to Chen et al. (2020) and Zhu et al. (2013).Entities:
Keywords: Genetics; High Throughput Screening; Model Organisms; Molecular/Chemical Probes; Plant sciences
Mesh:
Substances:
Year: 2021 PMID: 34041505 PMCID: PMC8144734 DOI: 10.1016/j.xpro.2021.100558
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Isolated mutants with abnormal Ca2+ signal response
| Mutant name | The phenotype of the mutants | Gene description | References |
|---|---|---|---|
| Reduced extracellular H2O2-induced and DMBQ-induced Ca2+ increase; insensitive to H2O2-induced stomatal closure and unresponsive to DMBQ | Leucine-rich-repeat receptor kinase | ( | |
| Reduced extracellular LPS-induced Ca2+ increase; LPS-insensitive | Lectin S-domain receptor kinase | ( | |
| Reduced extracellular ATP-induced Ca2+ increase | Lectin receptor kinase | ( | |
| Reduced salt stress-induced Ca2+ increase; hypersensitive to salt stress | Glucuronosyltransferase | ( | |
| Reduced hyperosmotic stress-induced Ca2+ increase; irresponsive to osmotic stress in ABA accumulation and gene expression | Ca2+-responsive phospholipid-binding protein | ( | |
| Reduced hyperosmotic stress-induced Ca2+ increase | Calcium channel | ( | |
| Reduced PAMP-induced Ca2+ increase | Calcium channels | ( | |
| Increased salt stress-induced Ca2+ increase | Actin-binding protein | ( | |
| Increased salt stress-induced Ca2+ increase | Glycosyltransferase | ( | |
| Reduced responses to HCO3−/CO2 for [Ca2+]cyt changes and stomatal movement | Unknown | ( | |
| Enhanced responses to HCO3−/CO2 for [Ca2+]cyt changes and stomatal movement | Unknown | ( |
The recommended ranges for stimuli
| Stimuli | Recommended concentrations | References |
|---|---|---|
| Gravity | ( | |
| Circadian | ( | |
| Light | ( | |
| Dark | ( | |
| Hyperosmotic stress | 200–600 mM mannitol, sorbitol, glucose, or sucrose | ( |
| NaCl | 75–200 mM NaCl | ( |
| Cold | 0°C–10°C | ( |
| Heat | 37°C–45°C | ( |
| Anoxia | ( | |
| pH | 3.5–4.5 | ( |
| Mechanical perturbation | Touch | ( |
| Wounding | Cropping | ( |
| H2O2 | 1–5 mM H2O2 | ( |
| cGMP | 10 μM | ( |
| cAMP | 10 μM | ( |
| GSH | 10–1000 μM | ( |
| GSSG | 1000 μM | ( |
| Nicotinamide | 50 mM | ( |
| NAD+ | 0.1–5 mM | ( |
| NADP+ | 0.1–5 mM | ( |
| NADH | 0.1–5 mM | ( |
| NADPH | 0.1–5 mM | ( |
| SNP | 5 μM–10 mM | ( |
| SNAP | 5 μM–500 μM | ( |
| Methanol | 0.1%–5% | ( |
| Flagellin | 0.125–2 μM | ( |
| Plant elicitor peptides | 20 nM–4 μM Pep1/3 | ( |
| Nucleotides | 10–1000 μM ATP/GTP | ( |
| L-Glu | 100 μM–10 mM | ( |
| L-Gly | 100 μM–10 mM | ( |
| Cys | 100 μM–10 mM | ( |
| L-Ser | 100 μM–10 mM | ( |
| L-Ala | 100 μM–10 mM | ( |
| L-Asp | 100 μM | ( |
| L-Asn | 100 μM–10 mM | ( |
| JA | 450–900 μM | ( |
| SA | 180 μM–5 mM | ( |
| Auxin | 167–500 μM IAA/NAA/2,4-D | ( |
| Gibberellin | 10–500 μM GA3/GA4 | ( |
| Cytokinin | 167–500 μM BAP | ( |
| Brassinolide | 100 mM eBL | ( |
| Cu2+ | 10 mM CuCl2 | ( |
| Cd2+ | 10 mM CdCl2 | ( |
Figure 1Identification of mutant candidates with reduced Ca2+ signal response
(A) Isolation of putative candidates with reduced osmotic stress-triggered Ca2+ luminescence response in the first-round screen. The seedlings with red circles are the candidates.
(B) Mutant candidate with reduced osmotic stress-induced Ca2+ luminescence response (left), but with similar discharged Ca2+ luminescence intensity (right).
(C) A false mutant candidate with reduced osmotic stress-induced Ca2+ luminescence response (left), but with reduced discharged Ca2+ luminescence intensity (right).
Scale bars, 1 cm.
Figure 2The workflow of EMS AEQub library screening for the mutants with altered Ca2+ response using the FAS system
(A) Prepare a square plate with 7-day-old seedlings (left) and an adhesive film (right).
(B) Place the film on the top of seedlings and gently touch the film to have seedlings adhered to.
(C–E) Peel the film (C) and place it into the plate containing coelenterazine solution with the seedlings side down (D) to have seedlings co-incubated with coelenterazine overnight (9–11 h) at room temperature (20°C–25°C) with gently shaking (E).
(F) Discard the coelenterazine solution and place the film back to the plate with the seedling side up.
(G and H) Acquire Ca2+ luminescence images for the first-round of the screen (G) and the second-round of verification (H).
Scale bars, 1 cm.
Figure 3Verification of mutant candidates
(A–C) Prepare mutant candidates for the second-round of FAS Ca2+ imaging as described above. Red-letter E is marked for the orientation of the film. The seedlings of each mutant together with wild type AEQub were grown in one line.
(D–F) Second-round of FAS Ca2+ imaging for mutant verification. Acquire H2O2 (D), NaCl (E), and mannitol (F) induced Ca2+ luminescence images for 160 s at an interval of 40 s.
(G) Acquire discharged images. Discard the stimuli and acquire images for one minute right after applying the discharge solution to stimuli-treated films.
(H) The third round of FAS Ca2+ imaging for mutant verification. Mutant candidates and wild-type control were grown on the same plate and transferred onto the same film for FAS Ca2+ imaging. Altered Ca2+ luminescence responses of the mutant were recorded under cold, oxidative, salt, and osmotic stress as compared to wild type.
Scale bars, 1 cm.
Figure 4Quantification of cytosolic Ca2+ elevation in mutant candidates with altered Ca2+ signal responses using a luminometer
(A) Quantification of cytosolic Ca2+ elevation in WT and m1 after treated with 400 mM mannitol.
(B) Quantification of cytosolic Ca2+ elevation in WT and m2 after treated with 5 mM H2O2.
Arrows indicate the time points for treatments.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Ethyl methanesulfonate (EMS) | Sigma-Aldrich | CAS# 594-43-4 |
| Potassium phosphate buffer (pH 7.5), 0.5 M, pH7.5 | TIANDZ | CAS# 25-05504 |
| NaOH | Sinopharm Chemical Reagent | CAS# 1310-73-2 |
| Sodium hypochlorite (NaClO) | Sinopharm Chemical Reagent | CAS# 7681-52-9 |
| Murashige & Skoog (MS) Basal Salt Mixture | PhytoTechnology | Cat#M524 |
| Sucrose | Sinopharm Chemical Reagent | CAS# 57-50-1 |
| Phytagel | Sigma-Aldrich | CAS# 71010-52-1 |
| Agar | Sigma-Aldrich | CAS# 9002-18-0 |
| Ethanol | Sigma-Aldrich | CAS# 64-17-5 |
| Triton X-100 | Sigma-Aldrich | CAS# 9002-93-1 |
| Mannitol | Sigma-Aldrich | CAS# 69-65-8 |
| H2O2 | Sigma-Aldrich | CAS# 7722-84-1 |
| NaCl | Sinopharm Chemical Reagent | CAS# 7647-14-5 |
| CaCl2.2H2O | Sigma-Aldrich | CAS# 10035-04-8 |
| Cefotaxime | Sigma-Aldrich | CAS# 64485-93-4 |
| HgCl2 | Sigma-Aldrich | CAS# 7487-94-7 |
| Nano Light | CAS# 50909-86-9 | |
| Widely distributed | N/A | |
| ( | N/A | |
| ( | N/A | |
| ( | N/A | |
| ( | N/A | |
| pMAQ | ( | N/A |
| WinView/32 | Roper | N/A |
| Cooled charge-coupled device | Princeton Instruments, New Jersey, USA | N/A |
| Luminometer | GloMax, Promega | N/A |
| Microplate reader | Molecular Devices | SpectraMax i3x |
| Percival incubator | Percival | CU36L5 |
| Adhesive PCR Plate Seals | Thermo Scientific | AB0558 |
Critical reagent
EMS working solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Ethyl methanesulfonate | 0.4% v/v | 80 μL |
| Potassium phosphate buffer (pH 7.5), 0.5 M | 100 mM | 4 mL |
| ddH2O | n/a | 16 mL |
Prepare the working solution on the day for sample processing.
Sodium hypochlorite solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Sodium hypochlorite (NaClO) | 5% v/v | 1 mL |
| ddH2O | n/a | 19 mL |
Prepare the working solution on the day for sample processing.
Bleach solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Bleach | 10% v/v | 2 mL |
| 10% Triton X-100 | 0.01% v/v | 20 μL |
| ddH2O | n/a | 18 mL |
Prepare the working solution on the day for sample processing.
HgCl2 solution
| Reagent | Final concentration | Amount |
|---|---|---|
| HgCl2 | 0.1% | 0.1 g |
| ddH2O | n/a | 100 mL |
Prepare the solution on the day for sample processing.
1/2 MS horizontal plates containing 1/2 MS nutrients, 1% sucrose, pH5.7
| Reagent | Final concentration | Amount |
|---|---|---|
| Murashige & Skoog (MS) Basal Salt Mixture | n/a | 2.17 g |
| Sucrose | 1 % | 10 g |
| Phytagel | 0.3% | 3 g |
| ddH2O | n/a | Up to 1 L |
1/2 MS vertical plates containing 1/2 MS nutrients, 1% sucrose, pH5.7
| Reagent | Final concentration | Amount |
|---|---|---|
| Murashige & Skoog (MS) Basal Salt Mixture | n/a | 2.17 g |
| Sucrose | 1% | 10 g |
| Phytagel | 0.6% | 6 g |
| ddH2O | n/a | Up to 1 L |
1/2 MS horizontal plates containing 1/2 MS nutrients, 25 mg/L cefotaxime, pH5.7
| Reagent | Final concentration | Amount |
|---|---|---|
| Murashige & Skoog (MS) Basal Salt Mixture | n/a | 2.17 g |
| Phytagel | 0.3% | 3 g |
| Cefotaxime stock solution, 25 mg/mL | 25 mg/L | 1 mL |
| ddH2O | n/a | Up to 1 L |
Adjust pH to 5.7 with 0.5 M KOH, and autoclave at 121°C for at least 15 min.
Coelenterazine h stock solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Coelenterazine h | 2 mM | 0.815 mg |
| Ethanol | n/a | 1 mL |
Protect against exposure to light and store at −80°C for up to 6 months.
Coelenterazine h working solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Coelenterazine h stock solution, 2 mM | 10 μM | 100 μL |
| 10% Triton X-100 | 0.1% v/v | 200 μL |
| ddH2O | n/a | 19.7 mL |
Prepare the working solution on the day for sample processing.
Mannitol solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Mannitol | 600 mM | 54.65 g |
| ddH2O | n/a | 500 mL |
Store at 4°C for up to 1 month.
NaCl solution
| Reagent | Final concentration | Amount |
|---|---|---|
| NaCl | 100 mM | 2.92 g |
| ddH2O | n/a | 500 mL |
Store at room temperature (20°C–25°C) for up to 1 month.
H2O2 solution
| Reagent | Final concentration | Amount |
|---|---|---|
| 30% H2O2 | 10 mM | 0.511 mL |
| ddH2O | n/a | 495 mL |
Prepare the working solution on the day for sample processing.
Discharging buffer
| Reagent | Final concentration | Amount |
|---|---|---|
| CaCl2.2H2O | 2 M | 147 g |
| Ethanol | 20% v/v | 100 mL |
| ddH2O | n/a | 364 mL |
Store at room temperature (20°C–25°C) for up to 1 month.
Cefotaxime stock solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Cefotaxime | 25 mg/mL | 250 mg |
| ddH2O | n/a | 10 mL |
Store at −20°C for up to 6 months.
Cefotaxime working solution
| Reagent | Final concentration | Amount |
|---|---|---|
| Cefotaxime stock solution, 25 mg/mL | 25 mg/L | 20 μL |
| ddH2O | n/a | 20 mL |
Prepare the working solution on the day for sample processing.